-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
- Reviva Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.46M, a 26.8% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$34.1M, a 13.9% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2023 was -$39.5M, a 39.9% decline from 2022.
- Reviva Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2022 was -$28.2M, a 179% decline from 2021.
- Reviva Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2021 was -$10.1M, a 315% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)